What is Qiagen N.V.'s Shariah compliance score?

Qiagen N.V. (QGEN) has a Shariah compliance score of 58/100 (Grade: C+, Fair) based on AAOIFI screening standards. Scores above 70 typically indicate strong compliance. The score factors in business activity screening and financial ratio analysis including debt levels, interest-bearing deposits, and prohibited income percentages. View the full breakdown at HalalScreener.app.

Does Qiagen N.V. pass AAOIFI screening?

Qiagen N.V. (QGEN) passes AAOIFI Shariah screening. AAOIFI requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30% (QGEN: 19.3%), (3) interest-bearing deposits below 30% (QGEN: 12.8%), and (4) prohibited income below 5% (QGEN: 3.1%). HalalScreener provides free AAOIFI screening for 10,000+ stocks at halalscreener.app.

How much purification is needed for Qiagen N.V. stock?

Qiagen N.V. (QGEN) has a non-permissible income ratio of 3.08%. Muslim investors should purify this percentage of any dividends received and capital gains realized from QGEN shares by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification automates this calculation using the latest financial data.

Where can I screen Qiagen N.V. for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for Qiagen N.V. (QGEN) and 10,000+ other US-listed stocks, ETFs, and 100+ cryptocurrencies. The screening uses AAOIFI Standard No. 21 and shows all financial ratios transparently. No credit card or signup required for basic screening. HalalScreener also includes an AI Islamic Scholar for follow-up questions about QGEN's compliance across different madhabs (Hanafi, Shafi'i, Maliki, Hanbali, Ja'fari).

QGEN: Is Qiagen N.V. Halal?

Qiagen N.V.

NYSEHealthcareNL

$41.51

-1.14%

Market Cap: 8.6B

Compliance Status

Halal

Screened on Jul 20, 2026 · AAOIFI Standard 21

C+

Fair

58Score

Is Qiagen N.V. (QGEN) halal? Halal. Based on AAOIFI screening, Qiagen N.V. passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 58/100 (Grade: C+).

AvoidBorderlineClean

Business activity

What the company sells is permissible.

Passed

Company debt

Within the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

19.3% of 30.0% limit

What this means for you

You can own QGEN

It passes both the business activity and financial ratio screens under AAOIFI Standard 21.

Purify 3.1% of your income from QGEN

That is about $3.10 of every $100 you earn from it. Donate this share to charity.

Calculate my exact amount

About Qiagen N.V.

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Sector: Healthcare · Industry: Medical - Diagnostics & Research

Shariah Compliance Status

AAOIFI Standard 21Updated Jul 20, 2026

Compliance History

Halal, unchanged since May 2026.

No status changes recorded since we began tracking.

Tracked since May 2026. Updates automatically on each re-screen.

Fiscal: FY 2025Data source: FMP

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

B+

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

B+

Free · No credit card required

Track QGEN and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

Get Started Free Browse Screener

10,000+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is Qiagen N.V. (QGEN) halal to invest in?

Based on AAOIFI Standard 21 screening, Qiagen N.V. (QGEN) is rated Halal with a compliance grade of C+ (Fair). It passes both the business activity screen (no primary involvement in prohibited sectors) and the quantitative financial ratio screen (debt, interest deposits, and prohibited income all below AAOIFI thresholds).

Why did Qiagen N.V. get a C+ compliance rating?

Qiagen N.V. (QGEN) received a grade of C+ (Fair) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 19.3% (limit 30%); interest-bearing deposits of 12.8% (limit 30%); prohibited income of 3.08% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.

What could change Qiagen N.V.'s Shariah verdict?

Qiagen N.V.'s verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

How often is Qiagen N.V. re-screened for Shariah compliance?

Qiagen N.V. (QGEN) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jul 20, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.